This may be attributed to an abundance of cAMP degrading isozymes (e.g. PDE4) known to be expressed in colon tumor cells [12] that could compensate for the effects of PDE10 inhibition or knockdown on cAMP signaling. The gene discussed is PDE4A; the disease is colonic neoplasm.